Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN – Module II

Sep 24, 2024

- Sep 23, 2025

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN

0.5

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs) credit

Already have an Account? Log In
Don’t have an account? Register Today

This course is available for logged in users only. Please login or register to take the course.

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeuti...

Update on Advanced Treatment Plans to Improve Outcomes for Patients with Primary Biliary C...

Update From ESC24: New Data on Non-Statin Lipid Lowering Therapies and Reduced CV Risk